课题基金 / 基金详情

MYOZYME TREATMENT IN PATIENTS WITH LATE ONSET POMPE DISEASE

MYOZYME TREATMENT IN PATIENTS WITH LATE ONSET POMPE DISEASE
Myozyme 治疗晚发性庞贝病患者
批准号：
7606598
负责人：
BRUCE A BARSHOP
金额：
$0.27万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606598
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseFundingGlycogen storage disease type IIGrantInstitutionPatientsPlacebosResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Health

项目摘要

项目成果

BRUCE A BARSHOP的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 评价美而赞治疗与安慰剂相比在晚发型庞贝氏症患者中的安全性、疗效和PK。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate the safety, efficacy and PK of Myozyme treatment in patients with late onset Pompe disease compared to placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CYSTEAMINE BITARTRATE DELAYED-RELESEASE CAPSULES (RP103) COMPARED TO CYSTEAMINE
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR
CLINICAL TRIAL: ALGLUCOSIDASE ALFA TEMPORARY ACCESS PROGRAM (ATAP) PROTOCOL AGLU
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR
海外基金